Efficacy of the low dose apatinib plus deep hyperthermia as third-line or later treatment in HER-2 negative advanced gastric cancer

Efficacy of the low dose apatinib plus deep hyperthermia as third-line or later treatment in HER-2 negative advanced gastric cancer

Aim: To observe the efficacy of the low dose apatinib plus deep hyperthermia as third-line or later treatment for patients with human epidermal growth factor receptor 2 (HER-2) negative advanced gastric cancer.Methods: 80 eligible patients with HER-2 negative advanced gastric cancer admitted to Jing...

Full description

Bibliographic Details
Main Authors: Guohu Han, Changchun Sun, Lihua Cui, Yufeng Huang, Lijiang Yu, Shenzha Liu, Min Tao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-07-01
Series:Pathology and Oncology Research
Subjects:
apatinib
deep hyperthermia
gastric cancer
efficacy evaluation
prognosis
Online Access:https://www.por-journal.com/articles/10.3389/pore.2023.1611114/full

Internet

https://www.por-journal.com/articles/10.3389/pore.2023.1611114/full

Similar Items